Initial evaluation of the Parent Cystic Fibrosis Questionnaire-Revised (CFQ-R) in infants and young children

Journal of Cystic Fibrosis

Volumn 14, Issue 3, 2015, Pages 403-411

  Alpern, Adrianne N ^a   Brumback, Lyndia C ^b   Ratjen, Felix ^c   Rosenfeld, Margaret ^d   Davis, Stephanie D ^e   Quittner, Alexandra L ^a  

^a Department of Biology   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e INDIANA UNIVERSITY   (United States)

Author keywords

Health related quality of life; Infants; Patient reported outome; Psychometric evaluation; Treatment burden

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; ISOTONIC SOLUTION; MUCOLYTIC AGENT; PANCREAS ENZYME; SODIUM CHLORIDE;

ACTIVITY OF DAILY LIVING ASSESSMENT; AGE; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL EVALUATION; CLINICAL FEATURE; CONSTRUCT VALIDITY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; EVALUATION AND FOLLOW UP; FEMALE; FUNCTIONAL STATUS ASSESSMENT; HUMAN; INFANT; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PARENT CYSTIC FIBROSIS QUESTIONNAIRE REVISED; PARENT SYMPTOM DIARY; PARENTAL BEHAVIOR; PSYCHOMETRY; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE ASSESSMENT; SYMPTOM ASSESSMENT; TREATMENT ADHERENCE QUESTIONNAIRE; TREATMENT BURDEN SCALE; ADOLESCENT; ADULT; CONTROLLED STUDY; HEALTH STATUS; INHALATIONAL DRUG ADMINISTRATION; PARENT; PRESCHOOL CHILD; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HEALTH STATUS; HUMANS; INFANT; MALE; PARENTS; PSYCHOMETRICS; QUALITY OF LIFE; SALINE SOLUTION, HYPERTONIC; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84937435578     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.11.002     Document Type: Article

References (30)

1. Wagener J.S., Zemanick E.T., Sontag M.K. Newborn screening for cystic fibrosis. Curr Opin Pediatr 2012, 24(3):329-335.
2. Linnane B.M., Hall G.L., Nolan G., Brennan S., Stick S.M., Sly P.D., et al. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med 2008, 178(12):1238-1244.
3. Quittner A., Alpern A., Kimberg C. Integrating patient-reported outcomes into research and clinical practice. Disorders of the respiratory tract in children 2012, 251-260. Elsevier, Oxford, UK. 8th ed. R.W. Wilmott, A. Bush, F. Ratjen, R. Deterding, T. Boat (Eds.).
4. Guidance for industry, patient-reported outcome measures: use in medical product development to support labeling claims http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf.
5. Scoggins J.F., Patrick D.L. The use of patient-reported outcomes instruments in registered clinical trials: evidence from ClinicalTrials.gov. Contemp Clin Trials 2009, 30(4):289-292.
6. Retsch-Bogart G.Z., Quittner A.L., Gibson R.L., Oermann C.M., McCoy K.S., Montgomery A.B., et al. Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis. Chest 2009, 135(5):1223-1232.
7. Quittner A.L., Butt A., Messer M.A., Modi A.C., Watrous M. Development and validation of the cystic fibrosis questionnaire in the United States-a health-related quality-of-life measure for cystic fibrosis. Chest 2005, 128(4):2347-2354.
8. Quittner A.L., Sawicki G.S., McMullen A., Rasouliyan L., Pasta D.J., Yegin A., et al. Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample. Qual Life Res 2012, 21(7):1267-1278.
9. Elkins M.R., Robinson M., Rose B.R., Harbour C., Moriarty C.P., Marks G.B., et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006, 354(3):229-240.
10. Amin R., Subbarao P., Jabar A., Balkovec S., Jensen R., Kerrigan S., et al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 2010, 65(5):379-383.
11. Ramsey B.W., Davies J., McElvaney N.G., Tullis E., Bell S.C., Drevinek P., et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011, 365(18):1663-1672.
12. Rosenfeld M., Ratjen F., Brumback L., Daniel S., Rowbotham R., McNamara S., et al. Inhaled hypertonic saline in infants and children younger than 6years with cystic fibrosis the ISIS randomized controlled trial. JAMA 2012, 307(21):2269-2277.
13. Brumback L., Baines M., Ratjen F., Davis S., Daniel S., Quittner A., et al. Pulmonary exacerbations and parent-reported outcomes in children <6 years with cystic fibrosis. Pediatric Pulmonology 2014.
14. Goss C.H., Quittner A.L. Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc 2007, 4(4):378-386.
15. Palermo T.M., Long A.C., Lewandowski A.S., Drotar D., Quittner A.L., Walker L.S. Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology. J Pediatr Psychol 2008, 33(9):983-996.
16. Accurso F.J., Rowe S.M., Clancy J.P., Boyle M.P., Dunitz J.M., Durie P.R., et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med 2010, 363(21):1991-2003.
17. Quittner A.L., Espelage D.L., Ievers-Landis C., Drotar D. Measuring adherence to medical treatments in childhood chronic illness: considering multiple methods and sources of information. J Clin Psychol Med Settings 2000, 7(1):41-54.
18. Goss C.H., Edwards T.C., Ramsey B.W., Aitken M.L., Patrick D.L. Patient-reported respiratory symptoms in cystic fibrosis. J Cyst Fibros 2009, 8(4):245-252.
19. Campbell D., Fiske D. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 1959, 56(2):81-105.
20. Nunnally J., Bernstein I. Psychometric theory 1994, McGraw-Hill, New York. 3rd ed.
21. Allison P. Change scores as dependent variables in regression analysis. Sociol Methodol 1990, 20:93-114.
22. Raat H., Landgraf J.M., Oostenbrink R., Moll H.A., Essink-Bot M.-L. Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample. Qual Life Res 2007, 16(3):445-460.
23. Stocks J., Lum S. Pulmonary function tests in infants and preschool children. Kendig and Chernick's disorders of the respiratory tract in children 2012, 169-210. Elsevier, Oxford, UK. 8th ed. R. Wilmott, A. Bush, F. Ratjen, R. Deterding, T. Boat (Eds.).
24. Bennett A.V., Patrick D.L., Lymp J.F., Edwards T.C., Goss C.H. Comparison of 7-day and repeated 24-hour recall of symptoms of cystic fibrosis. J Cyst Fibros 2010, 9(6):419-424.
25. Cruz I., Marciel K.K., Cheney J., Wainwright C., Campbell M., Quittner A.L. The Preschool Cystic Fibrosis Questionnaire-Revised: initial validation results. Pediatr Pulmonol 2009, 421-421.
26. Klassen A.F., Landgraf J.M., Lee S.K., Barer M., Raina P., Chan H.W.P., et al. Health related quality of life in 3 and 4year old children and their parents: preliminary findings about a new questionnaire. Health Qual Life Outcomes 2003, 1:81.
27. Mohangoo A.D., de Koning H.J., de Jongste J.C., Landgraf J.M., van der Wouden J.C., Jaddoe V.W.V., et al. Asthma-like symptoms in the first year of life and health-related quality of life at age 12months: the Generation R study. Qual Life Res 2012, 21(3):545-554.
28. Manificat S., Dazord A., Langue J., Danjou G., Bauche P., Bovet F., et al. Assessing infant's quality of life: validation of a new questionnaire. A multicentric European study. Arch Pediatr 2000, 7(6):605-614.
29. Detmar S.B., Muller M.J., Schornagel J.H., Wever L.D.V., Aaronson N.K. Health-related quality-of-life assessments and patient-physician communication-a randomized controlled trial. JAMA 2002, 288(23):3027-3034.
30. Feeny S. Preference-based measures: utility and quality-adjusted life years 2005, Oxford University Press, Oxford, UK.